This e-book explores the importance and challenges of improving patient response. It also provides in-depth analysis, insight and knowledge from the industry, including:
- Developments in combination therapies and the impact on patient response rates
- The use of precision medicine in immuno-oncology
- The impact of trial design on patient response rates and rational trial design vs. empirical science
- Regulatory challenges of immuno-oncology combinations with advanced therapy medicinal products
The common denominator across all of these insights is one of collaboration and partnerships, whether it’s between academia, biotech and big pharma, a sponsor and a vendor or two individuals with a common goal. Without ‘combinations’ and collaborations, we cannot hope to significantly improve patient response rates and, ultimately, improve the lives of patients in need.